BlackRock
MGCD

BlackRock’s MGC Diagnostics Corporation MGCD Stock Holding History

BlackRock’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-100,349
Closed -$901K – 5050
2017
Q3 		$901K Hold
100,349
– – ﹤0.01% 3940
2017
Q2 		$823K Sell
100,349
-4,524
-4% -$37.2K ﹤0.01% 3894
2017
Q1 		$877K Buy
+104,873
New +$925K ﹤0.01% 3840

Other funds holding MGCD

KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $891M AUM 30.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock's MGCD Position: Q4 2017 in Review

BlackRock sold out of MGC Diagnostics Corporation (MGCD) in Q4 2017, closing a stake of 100,349 shares — an estimated $901K sold.

BlackRock first reported a position in MGCD in Q1 2017 and held it in 3 quarters. The position peaked at $901K in Q3 2017. 12 funds tracked by Wall St. Rank hold MGCD as of Q4 2017.

  • BlackRock reported no remaining MGC Diagnostics Corporation position as of Q4 2017 after selling out during the quarter.
  • BlackRock sold 100,349 MGC Diagnostics Corporation shares in Q4 2017, an estimated $901K.
  • BlackRock first reported a position in MGC Diagnostics Corporation in Q1 2017 and held it in 3 quarters.
  • BlackRock's MGC Diagnostics Corporation position peaked at $901K in Q3 2017.
  • 12 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q4 2017.

Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.